Jump to the top of the page

William Blair Thinking

  • Navigating Economic Opportunities Amid Global Shifts

    Olga Bitel, partner and global strategist at William Blair, shares key insights into navigating the new reality as the global economic landscape shifts in response to the new U.S. administration’s policies, as investors face both challenges and significant opportunities.

    Read more
  • The Quarterly Rx: Q1 2025 U.S. Biopharma Recap

    On Groundhog Day 2025, Punxsutawney Phil saw his shadow and, as per tradition, predicted six more weeks of winter. That proved apropos of biopharma’s performance in the first quarter of 2025, as the sector finds itself reliving existential anxieties.

    Read more
  • Shaping the Future: Innovations and Trends in Obesity Treatment

    William Blair biotech analysts Matt Phipps and Andy Hsieh discuss Andy’s innovative scoring system for evaluating investigational agents in obesity treatment. This system, highlighted in Andy’s report “Shaping the Future: Innovations and Trends in Obesity Treatment,” considers both weight loss and gastrointestinal side effects to provide a more comprehensive clinical assessment. Tune in to hear their insights on the future of obesity therapies, upcoming industry catalysts, and more.

    Listen to the podcast

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Record-Breaking 30 William Blair Wealth Advisors Named Best-in-State by Forbes

    Congratulations to the firm’s largest group to make Forbes’ annual state listing, released on April 8.

    Read more
  • William Blair Adds Secondaries Lead in Europe

    William Blair announced today the continued growth of the firm’s Private Capital Advisory team in Europe with the addition of Tim-Oliver Seidel.

    Read more
  • William Blair Initiates Coverage of Two Companies Developing Retinal Disease Therapies

    William Blair initiated research coverage of Kalaris Therapeutics, Inc. (KLRS $7.08) and Ocular Therapeutix, Inc. (OCUL $6.36), both biotechnology companies developing therapies for the treatment of retinal vascular diseases.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures